GoviEx Uranium : Condensed Interim Consolidated Financial Statements for the Nine months ended September 30, 2021

Condensed Interim Consolidated Financial Statements of

GoviEx Uranium Inc.

For the nine months ended September 30, 2021 (Unaudited - Stated in U.S. Dollars)

Notice to Reader

The accompanying condensed interim consolidated financial statements of GoviEx Uranium Inc. have been prepared by and are the responsibility of GoviEx's management. Accordingly, the independent auditor of GoviEx has not performed a review of these condensed interim consolidated financial statements.

P a g e | 2

GoviEx Uranium Inc.

Condensed Interim Consolidated Statements of Financial Position

(Unaudited - Stated in thousands of U.S. dollars)

		September 30,	December 31,
	Notes	2021	2020
		$	$
Assets
Current assets
Cash		7,314	2,539
Amounts receivable		18	11
Marketable securities	3	43	118
Prepaid expenses and deposit		66	16
		7,441	2,684
Non-current assets
Long-term deposit		173	140
Plant and equipment		106	33
Mineral properties	4	69,591	69,591
		69,870	69,764
Total assets		77,311	72,448
Liabilities
Current liabilities
Accounts payable and accrued liabilities		605	600
Area tax payable	4 (a)	6,554	-
Non-current liabilities		7,159	600
Area tax payable		-	4,537
		7,159	5,137
Equity
Share capital	5	260,430	248,321
Contributed surplus		20,735	20,693
Deficit		(222,199)	(213,900)
Equity attributable to GoviEx Uranium Inc.		58,966	55,114
Non-controlling interest	4 (a)	11,186	12,197
		70,152	67,311
Total liabilities and equity		77,311	72,448

The accompanying notes are an integral part of the condensed interim consolidated financial statements. Nature of Operations and Going Concern (note 1)

Approved and authorized for issue on behalf of the Board of Directors on November 16, 2021.

/s/ "Benoit La Salle"		/s/ "Christopher Wallace "
Director		Director

Page | 3

GoviEx Uranium Inc.

Condensed Interim Consolidated Statements of Loss and Comprehensive Loss

(Unaudited - Stated in thousands of U.S. dollars, except for shares and per share amounts)

		Three months ended September 30,	Nine months ended September 30,
	Notes		2021		2020		2021		2020
			$		$		$		$
Expenses
Area tax	4(a)		-		-		(2,252)		(2,043)
Exploration and evaluation	7		(2,355)		(548)		(5,072)		(1,410)
General and administration	8		(524)		(315)		(1,544)		(1,033)
			(2,879)		(863)		(8,868)		(4,486)
Other income (expenses)
Change in fair value of marketable securities	3		(36)		(42)		(76)		45
Depreciation			(7)		(3)		(16)		(10)
Foreign exchange gain (loss)			(94)		(162)		271		(275)
Recovery of loan receivable			-		80		-		100
Interest and other			13		5		43		13
Share-based compensation	6(a)		(398)		(233)		(664)		(464)
			(522)		(355)		(442)		(591)
Loss and comprehensive loss for the period			(3,401)		(1,218)		(9,310)		(5,077)
Loss and comprehensive loss attributable to:
GoviEx Uranium Inc.			(3,035)		(1,201)		(8,299)		(4,843)
Non-controlling interest			(366)		(17)		(1,011)		(234)
Net loss for the period			(3,401)		(1,218)		(9,310)		(5,077)
Net loss per share, basic and diluted		$	(0.01)	$	(0.00)	$	(0.02)	$	(0.01)
Weighted average number of common shares
outstanding			540,015,980		460,405,650		528,064,764		443,553,004

The accompanying notes are an integral part of the condensed interim consolidated financial statements.

Page | 4

GoviEx Uranium Inc.

Condensed Interim Consolidated Statements of Changes in Equity

(Stated in thousands of U.S. dollars except for shares)

					Equity	Non-
	Number of	Share	Contributed		attributable to	controlling	Total
Notes	Shares	Capital	Surplus	Deficit	GoviEx	Interest	Equity
		$	$	$	$	$	$
Balance, December 31, 2019	423,322,362	243,254	19,888	(208,075)	55,067	12,820	67,887
Shares issued for cash, net of share issue costs	51,047,620	5,090	103	-	5,193	-	5,193
Shares issued for options exercised	480,000	58	(19)		39	-	39
Share-based compensation	-	-	465	-	465	-	465
Net loss for the period	-	-	-	(4,843)	(4,843)	(234)	(5,077)
Balance, September 30, 2020	474,849,982	248,402	20,437	(212,918)	55,921	12,586	68,507
Balance, December 31, 2020	475,799,982	248,321	20,693	(213,900)	55,114	12,197	67,311
Shares issued for cash, net of share issue costs	32,000,000	5,917	-	-	5,917	-	5,917
Shares issued for warrants exercised	27,001,470	4,543	-	-	4,543	-	4,543
Shares issued for options exercised	10,346,658	1,649	(621)	-	1,028	-	1,028
Share-based compensation	-	-	663	-	663	-	663
Net loss for the period	-	-	-	(8,299)	(8,299)	(1,011)	(9,310)
Balance, September 30, 2021	545,148,110	260,430	20,735	(222,199)	58,966	11,186	70,152

The accompanying notes are an integral part of the condensed interim consolidated financial statements.

Page | 5